High Vista Strategies LLC Akebia Therapeutics, Inc. Transaction History

High Vista Strategies LLC

  • $255 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$2.39 - $13.08 $28,202 - $154,344
-11,800 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$4.1 - $10.24 $7,789 - $19,456
-1,900 Reduced 13.87%
11,800 $89,000
Q4 2019

Feb 14, 2020
SELL
$3.16 - $6.73 $3,476 - $7,403
-1,100 Reduced 7.43%
13,700 $87,000
Q3 2019

Nov 14, 2019
BUY
$3.55 - $5.4 $52,540 - $79,920
14,800 New
14,800 $58,000

Others Institutions Holding AKBA

# of Institutions
121
Shares Held
54.8M
Call Options Held
291K
Put Options Held
179K
View Full List

About Akebia Therapeutics, Inc.

AKBA Quotes by TradingView
  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $338M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email